Related Experiment Video
Updated: Dec 20, 2025

Method of Studying Palatal Fusion using Static Organ Culture
Published on: September 19, 2015
Congenital Heart Disease in Patients With Cleft Lip/Palate and Its Impact on Cleft Management
Beina Azadgoli1, Naikhoba C O Munabi1, Artur Fahradyan2
1Division of Plastic and Reconstructive Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Insights
Congenital heart disease (CHD) is more common in patients with cleft lip and/or palate (CL/P), especially those with cleft palate. CHD requires careful management alongside cleft treatment to minimize complications like fistulas.
Area of Science:
- Craniofacial Surgery
- Pediatric Cardiology
- Medical Genetics
Background:
- Congenital heart disease (CHD) is a known comorbidity in patients with cleft lip and/or palate (CL/P).
- The prevalence and specific associations of CHD within the CL/P population require further elucidation.
Purpose of the Study:
- To evaluate the characteristics of CHD in patients with CL/P.
- To assess the association between CHD and cleft outcomes.
Main Methods:
- Retrospective review of 575 patients with CL/P undergoing primary cleft treatment (2009-2015).
- Analysis of patient demographics, prenatal/birth characteristics, CL/P details, syndromic status, and postoperative complications.
- Comparison of patients with (+CHD) versus without (-CHD) congenital heart disease using statistical tests.
Main Results:
- 14.4% of patients with CL/P (83/575) had CHD.
- CHD rates were significantly higher in patients with cleft palate (CP) compared to other cleft types (P = .009).
- Most CHD cases (97.6%) were diagnosed before cleft treatment; 27.7% required cardiac surgery prior to cleft repair. CHD was linked to delayed CP repair and increased fistula rates in isolated CP patients.
Conclusions:
- Congenital heart disease is notably more prevalent in CL/P patients, particularly those with CP.
- Severe CHD is typically diagnosed and managed before cleft care.
- Postoperative fistulas may be more frequent in CL/P patients with CHD, necessitating careful surgical planning and patient optimization.
Objective:
To evaluate characteristics of congenital heart disease (CHD) in patients with cleft lip and/or palate (CL/P) and assess potential associations with cleft outcomes.
Design:
Retrospective review of all patients with CL/P who underwent primary cleft treatment from 2009 to 2015.
Setting:
Children's Hospital Los Angeles, a tertiary hospital.
Patients:
Exclusion criteria included microform cleft lip diagnosis, international patients, and patients presenting for secondary repair or revision after primary repair at another institution.
Main Outcomes Measured:
Patient demographics, prenatal and birth characteristics, CL/P characteristics, syndromic status, postoperative complications, and other outcomes were analyzed relative to CHD diagnoses and management. Patients with CL/P with (+CHD) were compared to those without (-CHD) CHD using χ2 tests and analysis of variance.
Results:
Among 575 patients with CL/P, 83 (14.4%) had CHD. Congenital heart disease rates were significantly higher in patients with cleft palate (CP) compared to other cleft types (χ2, P = .009). Eighty-one (97.6%) out of 83 +CHD patients were diagnosed prior to initial CL/P surgical assessment. Twenty-three (27.7%) +CHD patients required surgical repair of 10 cardiac anomalies prior to cleft care. Congenital heart disease was associated with delayed CP repair and increased rates of fistula in isolated patients with CP.
Conclusions:
Congenital heart disease is known to be more prevalent in patients with CL/P. These data suggest the condition is particularly increased in patients with CP. Severe forms of CHD are diagnosed and treated prior to cleft care however postoperative fistula may be more common in patients with CHD. Therefore, careful attention is required for patient optimization and palatal flap dissection in patients with coexisting CHD and CL/P.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cardiopulmonary Resuscitation II: ACLS Airway Management

